SKY_1170x120_11-16-20

Aurobindo gets FDA approval for ketorolac tromethamine ophthalmic solution, 0.5%.

Print Friendly, PDF & Email

EAST WINDSOR, N.J. – Aurobindo Pharma has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application ketorolac tromethamine ophthalmic solution, 0.5%. Aurobindo Pharma’s ketorolac tromethamine ophthalmic solution, 0.5% are an AB-rated generic equivalent to the reference listed drug (RLD), Acular Ophthalmic Solution, 0.5% (Allergan, Inc.)

Ketorolac tromethamine ophthalmic solution is indicated for:

  • Temporary relief of ocular itching due to seasonal allergic conjunctivitis
  • Treatment of postoperative inflammation in patients who have undergone cataract extraction.


EMC_728x90

TRP_728x90_12-19-19

Comments are closed.